Robert Strayer

Rob Strayer serves as the Executive Vice President of Policy at the Information Technology Industry Council (ITI). He leads ITI’s efforts to shape technology policy around the world to enable innovation, competition, and economic growth, while supporting governments efforts to achieve their public policy objectives. Managing a team of experienced professionals at ITI, he is responsible for developing and executing policy strategies in major global markets and on a wide range of digital technology issues, including privacy and data protection, cybersecurity, trade and market access, taxation, artificial intelligence, and standards.

Prior to joining ITI, Strayer served as the Deputy Assistant Secretary of State for Cyber and International Communications Policy at the U.S. State Department. In that role, he led dozens of bilateral and multilateral dialogues with foreign governments on digital economy regulatory, cybersecurity, and technology supply chain security issues. He was named as an ambassador by the President to lead the 90-plus person U.S. delegation to the International Telecommunication Union (ITU) Plenipotentiary Conference in Dubai, United Arab Emirates in 2018.

Before joining the State Department, Strayer was the general counsel for the U.S. Senate Foreign Relations Committee. He also practiced telecommunications law at WilmerHale, and clerked for the U.S. Court of Appeals for the Eleventh Circuit.

Strayer received a law degree from Vanderbilt University Law School, and earned his B.A. in Economics, summa cum laude, from Denison University.

(Transcript) Protecting Intellectual Property for National Security: A Conversation with Rep. Nathaniel Moran (R-TX)

This transcript is from a CSIS and LeadershIP event hosted on December 3, 2024. Watch the full video here. John J. Hamre: Good afternoon, everybody. Welcome. We’re delighted to have you here. My name is John Hamre. I’m the president at CSIS. And this is going to be one
Read More

Generic Drugs, Property Rights, and the Orange Book

By Chris Borges Intellectual property (IP) rights secured through patents facilitate the introduction of dozens of new brand-name drugs and hundreds of generic drugs annually in the United States. However, proposals advanced by the Biden administration have mistakenly singled out patents as the cause of high drug prices, potentially harming the dense networks
Read More

Intellectual Property Rights and the Future of U.S. Technological Leadership

By Dr. Kirti Gupta This commentary is part of a report from the CSIS Economic Security and Technology Department, titled Staying Ahead in the Global Technology Race. The report features a set of essays outlining key issues on economic security for the next administration, including global technology competition, industrialization
Read More